In follicular, papillary, and anaplastic thyroid carcinomas, targeting the PAX8/peroxisome proliferator-activated receptors (PPARs) fusion protein is being considered as a potential mechanism for therapy. The gene discussed is PAX8; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.